Neurorestorative Therapy for Stroke
Open Access
- 27 June 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 8, 382
Abstract
Ischemic stroke is a major cause of death and long-term disability world wide. Development of effective therapy has been the target of intense research. Accumulating preclinical literature has shown that substantial functional improvement after stroke can be achieved using subacutely administered cell-based and pharmacological therapies. This review provides an update on bone marrow-derived mesenchymal stem cells (BMSCs), human umbilical cord blood cells (HUCBCs) and select pharmacological agents presently in clinical use for other indications, to promote recovery processes in the sub-acute and chronic phases after stroke. This review paper also focuses on molecular mechanisms underlying the cell-based and pharmacological restorative processes which enhance angiogenesis, arteriogenesis, neurogenesis and white matter remodeling following cerebral ischemia as well as an analysis of the interaction/coupling among these restorative events. In addition, the role of microRNAs (miRNAs) mediating the intercellular communication between exogenously administered cells and parenchymal cells, and their effects on the regulation of angiogenesis and neuronal progenitor cell proliferation and differentiation, and brain plasticity after stroke will be described.Keywords
This publication has 175 references indexed in Scilit:
- Niaspan increases axonal remodeling after stroke in type 1 diabetes ratsNeurobiology of Disease, 2012
- Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in ratsJournal of the Neurological Sciences, 2011
- Thrombolytic Therapy for Acute Ischemic Stroke beyond Three HoursThe Journal of Emergency Medicine, 2011
- Cord blood administration induces oligodendrocyte survival through alterations in gene expressionBrain Research, 2010
- Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcomeJournal of the Neurological Sciences, 2010
- Niaspan treatment induces neuroprotection after strokeNeurobiology of Disease, 2010
- Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b‐expressing, isolectin‐binding proinflammatory cells after middle cerebral artery occlusionJournal of Neuroscience Research, 2009
- Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of strokeNeurobiology of Disease, 2009
- Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognitionNeurobiology of Aging, 2009
- N-cadherin mediates nitric oxide-induced neurogenesis in young and retired breeder neurospheresNeuroscience, 2006